Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$427M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 3 |
STJ
St Jude Medical
STJ
|
+$235M |
| 4 |
JPMorgan Chase
JPM
|
+$211M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
PUT
Southern Company
SO
$107B
| $2.15M | ﹤0.01% |
43,100
-11,500
| -21% | -$568K |
|
|
RHT
2002
PUT
DELISTED
Red Hat Inc
RHT
| $2.15M | ﹤0.01% |
24,800
+9,600
| +63% | +$763K |
|
|
VCRA
2003
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $2.14M | ﹤0.01% |
86,221
+40,900
| +90% | +$866K |
|
2004
CALL
Lazard
LAZ
$4.31B
| $2.14M | ﹤0.01% |
46,500
+12,200
| +36% | +$526K |
|
2005
CALL
Nektar Therapeutics
NKTR
$2.58B
| $2.14M | ﹤0.01% |
6,073
+5,966
| +5,576% | +$1.34M |
|
|
BRSL
2006
Brightstar Lottery PLC
BRSL
$2.03B
| $2.14M | ﹤0.01% |
90,244
+69,313
| +331% | +$1.81M |
|
2007
CALL
Olin
OLN
$2.12B
| $2.13M | ﹤0.01% |
64,900
-8,300
| -11% | -$249K |
|
2008
CALL
Williams Companies
WMB
$86.1B
| $2.13M | ﹤0.01% |
72,100
-63,300
| -47% | -$1.83M |
|
2009
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
| $2.13M | ﹤0.01% |
20,194
+2,691
| +15% | +$283K |
|
2010
Factset
FDS
$10.2B
| $2.13M | ﹤0.01% |
12,904
+4,059
| +46% | +$710K |
|
2011
CALL
Golar LNG
GLNG
$5.13B
| $2.13M | ﹤0.01% |
76,100
-864,700
| -92% | -$23.1M |
|
2012
Vanguard FTSE Pacific ETF
VPL
$8.43B
| $2.13M | ﹤0.01% |
33,580
| – | – |
|
2013
CEMIG Preferred Shares
CIG
$6.01B
| $2.12M | ﹤0.01% |
1,266,586
+562,823
| +80% | +$875K |
|
|
ENDP
2014
DELISTED
Endo International plc
ENDP
| $2.12M | ﹤0.01% |
190,300
-189,513
| -50% | -$2.35M |
|
2015
CALL
Radware
RDWR
$1.19B
| $2.12M | ﹤0.01% |
+131,200
| New | +$2.02M |
|
2016
PUT
Ciena
CIEN
$58.4B
| $2.12M | ﹤0.01% |
89,700
-10,100
| -10% | -$248K |
|
|
AERI
2017
DELISTED
Aerie Pharmaceuticals
AERI
| $2.12M | ﹤0.01% |
46,661
+16,315
| +54% | +$728K |
|
|
2018
CALL
Southern Company
SO
$107B
| $2.11M | ﹤0.01% |
42,300
+1,600
| +4% | +$79.1K |
|
|
BID
2019
DELISTED
Sotheby's
BID
| $2.1M | ﹤0.01% |
46,312
+35,166
| +316% | +$1.5M |
|
2020
CALL
GoPro
GPRO
$126M
| $2.1M | ﹤0.01% |
241,700
-289,800
| -55% | -$2.63M |
|
2021
CALL
Acadia Pharmaceuticals
ACAD
$5.03B
| $2.1M | ﹤0.01% |
61,100
-540,300
| -90% | -$19.1M |
|
2022
PUT
Transocean
RIG
$5.82B
| $2.1M | ﹤0.01% |
168,600
-935,900
| -85% | -$12.9M |
|
|
DHC
2023
Diversified Healthcare Trust
DHC
$2.14B
| $2.1M | ﹤0.01% |
103,499
-38,938
| -27% | -$764K |
|
2024
CALL
JetBlue
JBLU
$2.29B
| $2.1M | ﹤0.01% |
101,800
-176,700
| -63% | -$3.6M |
|
2025
RLJ Lodging Trust
RLJ
$1.69B
| $2.1M | ﹤0.01% |
89,224
+73,054
| +452% | +$1.7M |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.86B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.